PH Awareness Month Invites People to Discover Pulmonary Hypertension - Pulmonary Hypertension News

---

PH Awareness Month Invites People to Discover Pulmonary Hypertension - Pulmonary Hypertension News Posted: 28 Oct 2020 05:00 AM PDT The Pulmonary Hypertension Association (PHA) is promoting several events throughout November — the Pulmonary Hypertension (PH) Awareness Month. This year, people are encouraged to discover the risk factors and symptoms of PH, and the challenges faced by those living with the disease, and their families. PH is often underdiagnosed and misunderstood, even among healthcare providers. Being aware of the disease's risk factors may reduce misdiagnoses, advocates say. There is a wide range of risk factors for PH, including other medical conditions such as connective tissue diseases, other lung disorders, or even drug abuse. Lung disorders that increase PF risk include chronic obstructive pulmonary disease, while connective tissue diseases such as scleroderma, which affect the tissues that support and hold organs together, also can be a factor. "It's critical for us to raise awareness of this rare and life-threatening disease," Colleen Brunetti, PH patient and PHA Board of Trustees chair, said in a press release. A monthlong online campaign will be held, aiming to bring awareness about PH to the general public, healthcare professionals, and members of the U.S. Congress. The campaign includes Facebook Live events, as well as advocacy and educational initiatives. "Educating patients, families, the medical community and policymakers about the symptoms, treatments and challenges of living with PH is essential to improving outcomes and quality of life," Brunetti said. On each day of November, an interactive calendar will reveal a new fact or resource to help spread awareness about the disease. A special focus is the Nov. 10 Day of Action, when people affected by PH will be invited to share their stories with the U.S. Congress. This initiative seeks to not only educate Congress about the impact of PH on people's lives but also to promote patient advocacy among U.S. senators and representatives. More information on the different advocacy initiatives organized by PHA can be found here. Several "Ask the Experts" sessions will be held throughout PH Awareness Month. These events aim to encourage people to ask questions of a vast panel of PH experts; they can be watched here or on the PHA's Facebook page. These sessions will start on Nov. 6 with Kristin Highland, MD, a PH specialist from Cleveland Clinic's Respiratory Institute. In this session, questions about the connection between PH and connective tissue diseases will be discussed. Particular attention will be paid to chronic thromboembolic pulmonary hypertension (CTEPH), a type of PH caused by blood clots in the lungs. On Nov. 11 — recognized this year as CTEPH Awareness Day — two dedicated sessions (one in English and the other in Spanish) will be conducted on Facebook. PH specialists Peter Hountras, MD, from the University of Colorado School of Medicine and Gustavo Heresi, MD, from Cleveland Clinic's Respiratory Institute will be answering questions about CTEPH. Yanny Lopez and Missy Storm, both CTEPH patients, will share their testimonies. PH will be addressed in an Ask the Expert session on Nov. 20 (in English) with Sonja Bartolome, MD, a PH specialist at UT Southwestern Medical Center. A session in Spanish will take place two days earlier, on Nov. 18, with Josanna Rodriguez-Lopez, MD, a PH specialist at Massachusetts General Hospital, and Margie Rodriguez, a specialist nurse on lung diseases. The link between methamphetamines and PH will be discussed on Nov. 23 in a live session with Ramona Doyle, MD, CEO of the Maven Project. A session in Spanish will be conducted on Nov. 24 by two PH specialists, Vinicio de Jesus Perez, MD, from Stanford University Medical Center, and Karla Cruz, MD, from Prisma Health/University of South Carolina. A toolkit is provided by the PHA with several resources available, including an awareness banner and a frame that can be added to profile pictures on social media. Information on how to conduct virtual fundraising opportunities also is available. The PHA is considered the oldest and largest nonprofit patient organization dedicated to the PH community in the U.S. As in previous years, Pulmonary Hypertension Awareness Month campaigns are also supported by Actelion Pharmaceuticals. Fact Checked By: Total Posts: 329 Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites. ×

Our current understanding of and approach to the management of lung cancer with pulmonary hypertension - DocWire News Posted: 26 Oct 2020 11:00 PM PDT This article was originally published here Expert Rev Respir Med. 2020 Oct 27. doi: 10.1080/17476348.2021.1842202. Online ahead of print. ABSTRACT INTRODUCTION: Lung cancer is a frequent pathology for which the best curative treatment is pulmonary resection. Pulmonary arterial hypertension is a rare disease but pulmonary hypertension associated with parenchymal disease or left heart disease is frequently observed in these patients. The diagnosis of pulmonary hypertension before lung resection makes the perioperative management of these patients more difficult and sometimes leads to rejecting patients for surgery. AREAS COVERED: We performed a review of literature on PubMed on Pulmonary hypertension associated lung resection, preoperative assessment of lung resection and perioperative management of PH patients, including guidelines and clinical trials. In this review, we summarize the current state of knowledge regarding the pre and perioperative management of patients with suspected or confirmed PH who can benefit from surgical treatment of lung cancer. EXPERT OPINION: Management of PH patients before lung resection should include a very careful workup including at least right heart catheterization with evaluation of the targeted PH treatment in an expert center and evaluation of other comorbidities. Perioperative management must be carried out in a specialized center. PMID:33107356 | DOI:10.1080/17476348.2021.1842202

You are subscribed to email updates from "pulmonary hypertension symptoms" - Google News. To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States